![Igor Minarik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Igor Minarik
Nessuna posizione attualmente
Profilo
Igor Minarik worked as a Vice President at KCR CRO GmbH.
Precedenti posizioni note di Igor Minarik
Società | Posizione | Fine |
---|---|---|
KCR CRO GmbH
![]() KCR CRO GmbH Miscellaneous Commercial ServicesCommercial Services KCR SA provides clinical research services. It operates as a European contract research organization and strategic solutions provider for companies who are looking for a reliable alternative to global contract research organizations. The firm’s services include clinical trial, functional service provision, and late phase studies. It offers clinical project management, clinical monitoring, site management, feasibility studies, regulatory affairs, site start-up and contracting, biometrics and data management, quality assurance, cross-functional sourcing model, functional sourcing model, post-authorization efficacy study, post-authorization safety study, pricing and market access research, and case control study. The company was founded by Marek Kiecana in 1997 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
KCR CRO GmbH
![]() KCR CRO GmbH Miscellaneous Commercial ServicesCommercial Services KCR SA provides clinical research services. It operates as a European contract research organization and strategic solutions provider for companies who are looking for a reliable alternative to global contract research organizations. The firm’s services include clinical trial, functional service provision, and late phase studies. It offers clinical project management, clinical monitoring, site management, feasibility studies, regulatory affairs, site start-up and contracting, biometrics and data management, quality assurance, cross-functional sourcing model, functional sourcing model, post-authorization efficacy study, post-authorization safety study, pricing and market access research, and case control study. The company was founded by Marek Kiecana in 1997 and is headquartered in Berlin, Germany. | Commercial Services |
- Borsa valori
- Insiders
- Igor Minarik